Proteomics and irritable bowel syndrome.

about

Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study.

P2860

Q52716489-9B6318F8-2FD7-4BBB-B1B5-FB160B3A3971

P2860

Proteomics and irritable bowel syndrome.

Item

http://www.wikidata.org/entity/Q39232397

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Proteomics and irritable bowel syndrome.

@en

Proteomics and irritable bowel syndrome.

@nl

type

Item

label

Proteomics and irritable bowel syndrome.

@en

Proteomics and irritable bowel syndrome.

@nl

prefLabel

Proteomics and irritable bowel syndrome.

@en

Proteomics and irritable bowel syndrome.

@nl

P1476

Proteomics and irritable bowel syndrome.

@en

P2093

Anna Vaiopoulou

http://www.w3.org/2001/XMLSchema#string

Athanasios K Anagnostopoulos

http://www.w3.org/2001/XMLSchema#string

Athanasios Tsigaridas

http://www.w3.org/2001/XMLSchema#string

Dimitrios G Karamanolis

http://www.w3.org/2001/XMLSchema#string

George Karamanolis

http://www.w3.org/2001/XMLSchema#string

George T Tsangaris

http://www.w3.org/2001/XMLSchema#string

Gerasimos J Mantzaris

http://www.w3.org/2001/XMLSchema#string

Ioannis S Papanikolaou

http://www.w3.org/2001/XMLSchema#string

Maria Gazouli

http://www.w3.org/2001/XMLSchema#string

Nikos Viazis

http://www.w3.org/2001/XMLSchema#string

P2860

An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome

Protein microarray technology

Overview of protein microarrays

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome

Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation

Correlation between protein and mRNA abundance in yeast

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Mass spectrometry-based proteomics turns quantitative

Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis--a pilot study

A proteome chip approach reveals new DNA damage recognition activities in Escherichia coli

P304

461-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14789450.2017.1317600

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28395553

http://www.w3.org/2001/XMLSchema#string

Proteomics and irritable bowel syndrome.

about

P2860

P2860

Proteomics and irritable bowel syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698